10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2022 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 8, 2023) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Revenues: | |||
| Premiums | $ 85,330 | 76,132 | 69,364 |
| Net investment income | 838 | 1,199 | 798 |
| Total revenues | 322,467 | 292,111 | 268,706 |
| Operating costs: | |||
| Cost of products sold | 196,892 | 175,803 | 163,981 |
| Benefit costs | 71,281 | 64,260 | 55,679 |
| Opioid litigation charges | 5,803 | 0 | 0 |
| Loss on assets held for sale | 2,533 | 0 | 0 |
| Store impairments | 0 | 1,358 | 0 |
| Goodwill impairment | 0 | 431 | 0 |
| Operating expenses | 38,212 | 37,066 | 35,135 |
| Total operating costs | 314,721 | 278,918 | 254,795 |
| Operating income | 7,746 | 13,193 | 13,911 |
| Interest expense | 2,287 | 2,503 | 2,907 |
| Loss on early extinguishment of debt | 0 | 452 | 1,440 |
| Other income | (169) | (182) | (206) |
| Income before income tax provision | 5,628 | 10,420 | 9,770 |
| Income tax provision | 1,463 | 2,522 | 2,569 |
| Income from continuing operations | 4,165 | 7,898 | 7,201 |
| Loss from discontinued operations, net of tax | 0 | 0 | (9) |
| Net income | 4,165 | 7,898 | 7,192 |
| Net (income) loss attributable to noncontrolling interests | (16) | 12 | (13) |
| Net income attributable to CVS Health | 4,149 | 7,910 | 7,179 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 3.16 | 6.00 | 5.49 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.00 | (0.01) |
| Net income attributable to CVS Health (in dollars per share) | 3.16 | 6.00 | 5.48 |
| Weighted average basic shares outstanding (in shares) | 1,312 | 1,319 | 1,309 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 3.14 | 5.95 | 5.47 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.00 | (0.01) |
| Net income attributable to CVS Health (in dollars per share) | 3.14 | 5.95 | 5.46 |
| Weighted average diluted shares outstanding (in shares) | 1,323 | 1,329 | 1,314 |
| Dividends declared per share (in dollars per share) | 2.20 | 2.00 | 2.00 |
| Cost, Product and Service [Extensible List] | http://fasb.org/us-gaap/2022#ProductMember | http://fasb.org/us-gaap/2022#ProductMember | http://fasb.org/us-gaap/2022#ProductMember |
| Product and Service | |||
| Products | |||
| Revenues | 226,616 | 203,738 | 190,688 |
| Services | |||
| Revenues | 9,683 | 11,042 | 7,856 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |